Metabolic Dysfunction-Associated Steatohepatitis

Metabolic dysfunction-associated steatohepatitis (MASH) is a serious liver condition where too much fat builds up in the liver, causing inflammation and damage. It was previously known as nonalcoholic steatohepatitis (NASH). MASH can lead to severe liver problems, including scarring (fibrosis), cirrhosis, and liver failure, if not managed effectively.

What is Metabolic Dysfunction-Associated Steatohepatitis?

Metabolic dysfunction-associated steatohepatitis (MASH) is a type of fatty liver disease where fat builds up in the liver, leading to inflammation and liver cell damage. This condition can progress to more serious liver problems over time. It is closely linked to metabolic risk factors like obesity and type 2 diabetes.

MASH is a progressive liver disease that affects many people worldwide. It occurs when excess fat accumulates in liver cells, a condition known as hepatic steatosis or fatty liver. Unlike fatty liver caused by heavy alcohol use, MASH is related to metabolic issues. The inflammation and damage in MASH can cause the liver to scar (fibrosis). Over time, this scarring can become severe, leading to cirrhosis, a condition where healthy liver tissue is replaced by scar tissue. Cirrhosis can impair the liver's ability to function properly and may lead to liver failure or liver cancer. Early detection and management are important to prevent or slow the progression of liver damage. MASH is part of a broader group of conditions called metabolic dysfunction-associated steatotic liver disease (MASLD), which was previously known as nonalcoholic fatty liver disease (NAFLD). MASH is the more severe form of MASLD, characterized by both fat accumulation and inflammation, distinguishing it from simple fatty liver (steatosis) without significant inflammation.

Symptoms

Many people with metabolic dysfunction-associated steatohepatitis (MASH) have no symptoms, especially in the early stages. When symptoms do appear, they are often vague and can include fatigue, general discomfort, or a dull ache in the upper right side of the abdomen.

Because MASH often has no noticeable symptoms in its early stages, it can go undiagnosed for a long time. This makes regular check-ups important, especially for individuals with risk factors. When symptoms do occur, they are usually mild and non-specific, meaning they could be related to many different conditions. As the disease progresses and liver damage becomes more severe, particularly if it advances to cirrhosis, more noticeable symptoms may develop. These can include yellowing of the skin and eyes (jaundice), swelling in the legs and ankles (edema), fluid buildup in the abdomen (ascites), easy bruising or bleeding, and confusion or difficulty concentrating (hepatic encephalopathy). Other possible symptoms in advanced stages might include dark urine, pale stools, severe itching, and spider-like blood vessels visible under the skin (spider angiomas). These more severe symptoms indicate significant liver dysfunction and require immediate medical attention.

Causes & risk factors

Metabolic dysfunction-associated steatohepatitis (MASH) is caused by a combination of genetic and environmental factors that lead to fat buildup, inflammation, and damage in the liver. Key risk factors include obesity, type 2 diabetes, high cholesterol, high triglycerides, and high blood pressure, often grouped as metabolic syndrome.

MASH is not caused by heavy alcohol use, but rather by metabolic issues. The exact mechanisms are complex, but they involve the body's inability to process fats and sugars properly. This often starts with insulin resistance, a condition where the body's cells don't respond effectively to insulin, leading to higher blood sugar levels. Several conditions significantly increase your risk of developing MASH. These include being overweight or obese, especially with excess belly fat. Type 2 diabetes is another major risk factor, as is having high levels of cholesterol or triglycerides in your blood. High blood pressure (hypertension) also contributes to the risk. When several of these risk factors are present together, it's known as metabolic syndrome. People with metabolic syndrome are at a much higher risk of developing MASH. Other risk factors can include certain genetic predispositions, rapid weight loss, and some medications. It's important to note that not everyone with these risk factors will develop MASH, and some people without obvious risk factors can still get it.

How it's diagnosed

Diagnosing metabolic dysfunction-associated steatohepatitis (MASH) typically involves a combination of blood tests, imaging studies, and sometimes a liver biopsy. Blood tests can check liver enzyme levels and rule out other conditions, while imaging helps visualize fat in the liver. A liver biopsy is often the most definitive way to confirm MASH and assess liver damage.

Your doctor will usually start by reviewing your medical history and performing a physical exam. They will ask about your lifestyle, including diet and exercise habits, and any medications you are taking. Initial blood tests may be ordered to check for elevated liver enzymes, which can indicate liver inflammation or damage. These tests also help rule out other causes of liver disease, such as viral hepatitis or alcohol-related liver disease. Imaging tests are often used to look for fat in the liver. These can include an ultrasound, computed tomography (CT) scan, or magnetic resonance imaging (MRI). Specialized MRI techniques, such as magnetic resonance elastography (MRE), can also help measure liver stiffness, which is a sign of scarring (fibrosis). While imaging can show fat, it cannot definitively distinguish between simple fatty liver and MASH. To confirm a diagnosis of MASH and determine the extent of liver inflammation and scarring, a liver biopsy is often necessary. During a biopsy, a small sample of liver tissue is removed, usually with a needle, and examined under a microscope. This procedure helps doctors assess the severity of inflammation, fat accumulation, and fibrosis, guiding treatment decisions. However, due to its invasive nature, doctors may try to diagnose MASH without a biopsy in some cases.

Treatment options

Treatment for metabolic dysfunction-associated steatohepatitis (MASH) primarily focuses on managing underlying metabolic conditions and making lifestyle changes. These include losing weight, eating a healthy diet, and increasing physical activity. There are currently no specific medications approved solely for MASH, but some drugs for related conditions may help.

The cornerstone of MASH treatment involves lifestyle modifications. Achieving and maintaining a healthy weight is crucial, as even a modest weight loss of 3% to 5% can reduce fat in the liver, and losing 7% to 10% of body weight can improve inflammation and fibrosis. This is often achieved through a balanced diet rich in fruits, vegetables, and whole grains, while limiting processed foods, sugary drinks, and unhealthy fats. Regular physical activity is also highly recommended. Aiming for at least 150 minutes of moderate-intensity exercise per week can help with weight loss, improve insulin sensitivity, and reduce liver fat. These lifestyle changes not only help manage MASH but also improve associated conditions like type 2 diabetes, high cholesterol, and high blood pressure. While there are no medications specifically approved to treat MASH itself, your doctor may prescribe medications to manage related conditions. For example, drugs to control blood sugar in people with type 2 diabetes, lower cholesterol, or manage high blood pressure can indirectly benefit the liver. In some cases, vitamin E may be considered for people without diabetes, but its use should be discussed with a doctor due to potential risks. Research is ongoing to develop new medications specifically targeting MASH.

Recovery & outlook

The outlook for metabolic dysfunction-associated steatohepatitis (MASH) varies greatly depending on the stage of the disease and how well underlying conditions are managed. With significant lifestyle changes and medical management, it is possible to slow or even reverse liver damage in early stages. However, if MASH progresses to advanced scarring (cirrhosis), the outlook becomes more serious.

For many people, especially those diagnosed in earlier stages, making lifestyle changes can significantly improve MASH. Losing weight, adopting a healthy diet, and exercising regularly can reduce liver fat, inflammation, and even improve fibrosis. This can prevent the disease from progressing to more severe stages and may lead to a better quality of life. However, if MASH is left unmanaged, it can progress to more serious conditions. About 1 in 5 people (20%) with MASH may develop cirrhosis, a severe scarring of the liver that can lead to liver failure. Once cirrhosis is established, it is generally irreversible, and the risk of complications like liver cancer increases significantly. People with advanced MASH or cirrhosis require ongoing medical monitoring and management to prevent complications. In cases of end-stage liver disease, a liver transplant may be the only treatment option. Therefore, early diagnosis, consistent management of risk factors, and adherence to treatment plans are critical for a positive long-term outlook.

When to see a doctor

You should see a doctor if you have risk factors for metabolic dysfunction-associated steatohepatitis (MASH), such as obesity, type 2 diabetes, or high cholesterol, even if you have no symptoms. Seek immediate medical attention if you develop severe symptoms like yellowing skin or eyes (jaundice), severe abdominal pain, swelling in your legs or abdomen, or confusion.

Because MASH often has no symptoms in its early stages, it's important to discuss your risk factors with your doctor during routine check-ups. If you have conditions like type 2 diabetes, high blood pressure, or high cholesterol, or if you are overweight or obese, your doctor may recommend screening tests to check your liver health. If you experience persistent, vague symptoms such as ongoing fatigue, unexplained weakness, or a dull ache in your upper right abdomen, it's a good idea to consult your doctor. While these symptoms can be caused by many things, they could also be early signs of liver issues. Seek urgent medical care if you develop signs of advanced liver disease. These include yellowing of your skin or the whites of your eyes (jaundice), dark urine, pale stools, severe swelling in your legs, ankles, or abdomen (ascites), easy bruising or bleeding, or any changes in your mental state, such as confusion, disorientation, or difficulty concentrating. These symptoms could indicate serious liver damage requiring prompt evaluation.

Frequently asked questions

What is the difference between MASLD and MASH?

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the new umbrella term for fatty liver disease not caused by alcohol. Metabolic dysfunction-associated steatohepatitis (MASH) is a more severe form of MASLD where, in addition to fat in the liver, there is also inflammation and liver cell damage. Not all people with MASLD develop MASH.

Can MASH be reversed?

In its early stages, MASH can sometimes be reversed or significantly improved through lifestyle changes, such as weight loss, healthy eating, and regular exercise. Reducing liver fat and inflammation can help prevent the disease from progressing. However, once advanced scarring (cirrhosis) has developed, it is generally irreversible.

What foods should I avoid if I have MASH?

If you have MASH, it's generally recommended to avoid foods high in added sugars (especially sugary drinks), refined carbohydrates (like white bread and pasta), and unhealthy fats (saturated and trans fats found in processed foods and fried items). Focus on a diet rich in fruits, vegetables, lean proteins, and whole grains.

Is MASH hereditary?

While MASH itself is not directly inherited like some genetic diseases, there can be a genetic predisposition. Certain genes can increase your risk of developing MASH, especially when combined with metabolic risk factors like obesity, type 2 diabetes, and high cholesterol. If close family members have MASH, your risk might be higher.

How often should I be monitored if I have MASH?

The frequency of monitoring for MASH depends on the stage of your disease and your individual risk factors. Your doctor will typically recommend regular follow-up appointments, which may include blood tests to check liver function and imaging studies to assess liver fat and scarring. People with advanced fibrosis or cirrhosis may require more frequent monitoring.

Can MASH lead to liver cancer?

Yes, MASH can increase your risk of developing liver cancer, specifically hepatocellular carcinoma (HCC). This risk is significantly higher if MASH progresses to cirrhosis. Regular monitoring and managing the underlying MASH are crucial to reduce this risk and detect any potential cancer early.

Sources

• MedlinePlus — Metabolic Dysfunction-Associated Steatohepatitis
• Mayo Clinic — Metabolic Dysfunction-Associated Steatohepatitis
• Cochrane Library — Metabolic Dysfunction-Associated Steatohepatitis